<p>New Delhi, Jul 17 CORONA Remedies on Thursday said it has acquired seven brands from the pharmaceutical division of Bayer in India for an undisclosed sum.</p>.<p>The acquisition includes brands in the cardiology segment (Noklot) and women's healthcare portfolio (Fostine, Luprofact, Menodac, Ovidac, Spye and Vageston) in the Indian market, the company said in a statement.</p>.<p>Through the acquisition, the company said it is entering the anti-platelet monotherapy segment while also increasing presence in the cardiology domain. </p>
<p>New Delhi, Jul 17 CORONA Remedies on Thursday said it has acquired seven brands from the pharmaceutical division of Bayer in India for an undisclosed sum.</p>.<p>The acquisition includes brands in the cardiology segment (Noklot) and women's healthcare portfolio (Fostine, Luprofact, Menodac, Ovidac, Spye and Vageston) in the Indian market, the company said in a statement.</p>.<p>Through the acquisition, the company said it is entering the anti-platelet monotherapy segment while also increasing presence in the cardiology domain. </p>